Emma Walmsley
Chief Executive Officer bei GSK PLC
Vermögen: 47 Mio $ am 31.03.2024
Profil
Emma N. Walmsley ist Mitglied des Vorstands der Microsoft Corp. und Chief Executive Officer & Executive Director bei GlaxoSmithKline Plc. In ihrer bisherigen Laufbahn war Frau Walmsley Präsidentin der GlaxoSmithKline Consumer Healthcare Holdings Ltd. und General Manager-Consumer Products bei L'Oreal (China) Co. Ltd. Emma N. Walmsley hat einen Hochschulabschluss von der Universität Oxford.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
GSK PLC
0,05% | 16.04.2024 | 1 976 116 ( 0,05% ) | 43 Mio $ | 31.03.2024 |
MICROSOFT CORPORATION
0,00% | 31.01.2024 | 9 914 ( 0,00% ) | 4 Mio $ | 31.03.2024 |
Aktuelle Nachrichten zu Emma Walmsley
Aktive Positionen von Emma Walmsley
| Unternehmen | Position | Beginn |
|---|---|---|
| GSK PLC | Chief Executive Officer | 01.04.2017 |
| MICROSOFT CORPORATION | Director/Board Member | 01.12.2019 |
Glaxosmithkline Australia Pty Ltd.
 Glaxosmithkline Australia Pty Ltd. Pharmaceuticals: MajorHealth Technology Glaxosmithkline Australia Pty Ltd. manufactures and markets prescription medicines, prescribed vaccines, and consumer healthcare products. It serves healthcare professionals and consumers. The company was founded in 1886 and is headquartered in Melbourne, Australia. | Chief Executive Officer | - |
Stanford Medicine
 Stanford Medicine Hospital/Nursing ManagementHealth Services Stanford Medicine is an integrated academic health system that includes the Stanford School of Medicine and adult and pediatric health care delivery systems. The private company is based in Stanford, CA. The company focuses on collaborative research, education, and clinical care for patients to harness the full potential of biomedicine. | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Emma Walmsley
| Unternehmen | Position | Ende |
|---|---|---|
Haleon UK Holdings (No.2) Ltd.
 Haleon UK Holdings (No.2) Ltd. Financial ConglomeratesFinance Part of Haleon Plc, Haleon UK Holdings (No.2) Ltd. is an investment holding private company. Haleon UK Holdings (No.2) Ltd. is based in Weybridge, UK. Founded in 2019, Haleon UK Holdings (No.2 functions as an investment holding company. | Director/Board Member | 18.07.2022 |
| DIAGEO PLC | Director/Board Member | 21.09.2016 |
GlaxoSmithKline Consumer Healthcare Pte Ltd.
 GlaxoSmithKline Consumer Healthcare Pte Ltd. Food: Major DiversifiedConsumer Non-Durables Part of GSK Plc, GlaxoSmithKline Consumer Healthcare Pte Ltd. is a Singaporean company that manufactures and distributes healthcare foods, drugs, pharmaceuticals, and dairy products. The private company is based in Singapore, Singapore. | Chief Executive Officer | - |
GlaxoSmithKline Consumer Healthcare Holdings Ltd.
 GlaxoSmithKline Consumer Healthcare Holdings Ltd. Financial ConglomeratesFinance Part of GSK Plc, GlaxoSmithKline Consumer Healthcare Holdings Ltd. functions as an investment holding British company. The private company is based in Brentford, UK. | Chief Executive Officer | - |
L'Oreal (China) Co., Ltd.
 L'Oreal (China) Co., Ltd. Household/Personal CareConsumer Non-Durables Part of L'Oréal SA, L'Oreal (China) Co., Ltd. manufactures and markets personal care products. Fabrice Megarbane has been the CEO of the Chinese company since 2000. | Corporate Officer/Principal | - |
Ausbildung von Emma Walmsley
| University of Oxford | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| MICROSOFT CORPORATION | Technology Services |
| DIAGEO PLC | Consumer Non-Durables |
| GSK PLC | Health Technology |
| Private Unternehmen | 6 |
|---|---|
L'Oreal (China) Co., Ltd.
L'Oreal (China) Co., Ltd. Household/Personal CareConsumer Non-Durables Part of L'Oréal SA, L'Oreal (China) Co., Ltd. manufactures and markets personal care products. Fabrice Megarbane has been the CEO of the Chinese company since 2000. | Consumer Non-Durables |
GlaxoSmithKline Consumer Healthcare Pte Ltd.
GlaxoSmithKline Consumer Healthcare Pte Ltd. Food: Major DiversifiedConsumer Non-Durables Part of GSK Plc, GlaxoSmithKline Consumer Healthcare Pte Ltd. is a Singaporean company that manufactures and distributes healthcare foods, drugs, pharmaceuticals, and dairy products. The private company is based in Singapore, Singapore. | Consumer Non-Durables |
GlaxoSmithKline Consumer Healthcare Holdings Ltd.
GlaxoSmithKline Consumer Healthcare Holdings Ltd. Financial ConglomeratesFinance Part of GSK Plc, GlaxoSmithKline Consumer Healthcare Holdings Ltd. functions as an investment holding British company. The private company is based in Brentford, UK. | Finance |
Glaxosmithkline Australia Pty Ltd.
Glaxosmithkline Australia Pty Ltd. Pharmaceuticals: MajorHealth Technology Glaxosmithkline Australia Pty Ltd. manufactures and markets prescription medicines, prescribed vaccines, and consumer healthcare products. It serves healthcare professionals and consumers. The company was founded in 1886 and is headquartered in Melbourne, Australia. | Health Technology |
Haleon UK Holdings (No.2) Ltd.
Haleon UK Holdings (No.2) Ltd. Financial ConglomeratesFinance Part of Haleon Plc, Haleon UK Holdings (No.2) Ltd. is an investment holding private company. Haleon UK Holdings (No.2) Ltd. is based in Weybridge, UK. Founded in 2019, Haleon UK Holdings (No.2 functions as an investment holding company. | Finance |
Stanford Medicine
Stanford Medicine Hospital/Nursing ManagementHealth Services Stanford Medicine is an integrated academic health system that includes the Stanford School of Medicine and adult and pediatric health care delivery systems. The private company is based in Stanford, CA. The company focuses on collaborative research, education, and clinical care for patients to harness the full potential of biomedicine. | Health Services |
